In a research, scientists found that some of the special proteins present in the body become the enemy of prostate cancer drugs. This protein not only weakens the treatment but can also worsen the patient’s condition.
General prostate cancer in men
Prostate cancer is a disease related to men’s reproductive system. Which starts in the prostate gland. In the early stages, it grows slowly and the symptoms are very small. But when it starts to grow. Symptoms such as urination, bleeding, waist or bone pain appear. Scientists have found in their studies that AR-V7 and other types of protein work against prostate cancer drugs. This protein gives cancer cells the power to fight the drug. Due to which the drug is not effective. This is the reason why the effect of treatment on many patients does not last long and their condition begins to deteriorate.
Hormone blocking drugs
Hormone blocking drugs are usually given in the treatment of prostate cancer. But when this protein is activated. Then cancer cells find ways to prevent medicine. Because of this, cancer cells begin to grow again and the patient’s condition can worsen. The biggest result of this research is that doctors can now check how active this protein is in the patient’s body before starting the medication. If protein is more active. So the doctor may immediately choose another treatment or advanced treatment.
Protein is more important to check
Scientists are now working on targeted drugs. Which can block this protein. If these drugs are successful. So prostate cancer patients will benefit longer and their life will be good. Cancer experts believe that treatment may not be the same for every patient. If doctors identify this protein in advance, treatment can be more effective and safer.
Disclaimer: Some information in the news is based on media reports. Message News does not confirm the matter. You should consult a relevant specialist before implementing any suggestion.
